Investors Fight CBD Co.'s Bid To Ax Suit Over Clinical Trial
Investors accusing CBD drugmaker Zynerba Pharmaceuticals of withholding worrisome clinical trial results from the public have told a Pennsylvania federal court that the company can't beat their proposed class action by...To view the full article, register now.
Already a subscriber? Click here to view full article